Australian government provides grant worth $3 M for better wound care

The hidden epidemic of chronic wounds in Australia will be tackled through new initiatives funded with more than $3 mill...

March 18, 2024 | Monday | News
Novartis expands its biopharmaceutical manufacturing site in Singapore

Novartis is investing $256 million to expand its biopharmaceutical manufacturing plant in Singapore. The extended s...

March 15, 2024 | Friday | Company results
Zika virus vaccine emerges as tool in battling brain cancer: Singaporean study

Scientists from Duke-NUS Medical School (Duke-NUS) at Singapore have developed a new approach using the Zika virus to de...

March 11, 2024 | Monday | News
Taiwan’s BioGate Precision Medicine Corp develops pancreatic cancer therapy

Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...

March 7, 2024 | Thursday | News
First ever large-scale GMP manufacturing of therapeutic IgE antibody achieved in the UK

Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...

March 5, 2024 | Tuesday | News
Novel platform can significantly reduces drug testing and screening time in cancer diagnosis

In a breakthrough for personalised oncology, scientists from the National University of Singapore (NUS) and the National...

March 4, 2024 | Monday | News
Korea develops implant coating triggering antibiotic release against bacterial infection

A collaborative research team from the Department of Chemical Engineering and the School of Convergence Science and Tech...

March 4, 2024 | Monday | News
"One example of success is the development of a potential new paediatric treatment for schistosomiasis"

Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...

March 1, 2024 | Friday | Opinion
Korea using new rapid test for early outbreak control of Hantavirus

Orthohantaviruses, highly transmissible zoonotic pathogens, are notorious for causing haemorrhagic fever with renal synd...

March 1, 2024 | Friday | News
Malaysia's trajectory in redefining Cancer Treatment Standards

As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earni...

February 22, 2024 | Thursday | Analysis
Daiichi Sankyo unveils APAC regional hub for RDPV QA operations in Singapore

Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...

February 22, 2024 | Thursday | Company results
Singapore approves AffaMed Therapeutics drug for Ocular Inflammation

China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...

February 21, 2024 | Wednesday | News
Australian govt injects $50 M to construct world-leading artificial heart

The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...

February 20, 2024 | Tuesday | News
Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia

Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...

February 20, 2024 | Tuesday | News
China develops potential new treatment for brain tumours and Parkinson’s disease

A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...

February 15, 2024 | Thursday | News
Latest insights on genetic testing related hearing loss

According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...

February 9, 2024 | Friday | Analysis
Korean startup C-Biomex announces oncology research partnership with US-based MD Anderson

The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...

February 12, 2024 | Monday | News
Australia's Recce partners Indonesia's Etana Biotech to advance anti-infective R&D, manufacturing 

Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...

February 8, 2024 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls